GlassScriptPhysician profile
Richard H Taus
NPI 1710936513
$3,175.62
in general payments reported to CMS, 2019-2025
9 companies · $1,318 in 2025
The $1,318 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2021: $169 · 2022: $567 · 2024: $530 · 2025: $1,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,009 · Travel and Lodging: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,008.94 |
| Travel and Lodging | $838.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,079.06 | 2025 | Indigo System |
| Medtronic, INC. | $484.09 | 2022-2024 | Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $368.50 | 2019-2024 | Embold Fibered |
| Cook Medical LLC | $297.14 | 2019 | |
| Heartflow, INC. | $238.69 | 2025 | |
| Abbott Laboratories | $198.78 | 2022 | |
| Si-Bone, INC. | $181.97 | 2024 | |
| Stryker Corporation | $173.00 | 2024 | Spinejack |
| Medtronic USA, INC. | $154.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Taus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.